Table 4.

Neurocognitive mean z scores comparing the composite scores for the SCA sample at months 0 and 18

Composite test (age in y)SCA at
month 0
SCA at
month 18
Difference P value
KABC-II MPI (≥4 y) n = 208† n = 202  n = 201  
Cognition −0.54 ± 1.10 −0.07 ± 1.16 0.45 ± 0.84 <.001 
TOVA D’ (≥5 y) n = 152 n = 150 n = 146  
Attention −0.07 ± 1.01 0.27 ± 0.84 0.35 ± 0.97 <.001 
BRIEF GEC (all ages)  n = 264 n = 254 n = 254  
Executive function −0.06 ± 0.62 0.08 ± 0.72 −0.15 ± 0.92 .010 
NEPSY-II AAR (≥7 y) n = 60 n = 62 n = 59  
Executive function −0.38 ± 0.93 −0.09 ± 0.97 0.32 ± 1.18 .035 
Composite test (age in y)SCA at
month 0
SCA at
month 18
Difference P value
KABC-II MPI (≥4 y) n = 208† n = 202  n = 201  
Cognition −0.54 ± 1.10 −0.07 ± 1.16 0.45 ± 0.84 <.001 
TOVA D’ (≥5 y) n = 152 n = 150 n = 146  
Attention −0.07 ± 1.01 0.27 ± 0.84 0.35 ± 0.97 <.001 
BRIEF GEC (all ages)  n = 264 n = 254 n = 254  
Executive function −0.06 ± 0.62 0.08 ± 0.72 −0.15 ± 0.92 .010 
NEPSY-II AAR (≥7 y) n = 60 n = 62 n = 59  
Executive function −0.38 ± 0.93 −0.09 ± 0.97 0.32 ± 1.18 .035 

Bold values indicate significance at P < .5.

For each measure, the same participants were compared between the 2 time points.

BRIEF GEC, Behavior Rating Inventory of Executive Function Global Executive Composite; KABC-II MPI, Kaufman Assessment Battery for Children, second edition, Mental Processing Index; NEPSY-II AAR, Developmental Neuropsychological Assessment; TOVA, Test of Variables of Attention.

The same participant sample was compared in the analysis of each measure.

17 (8.2%) were cognitively impaired (z score below −2.0) at enrollment compared with 8 (4.0%) at month 18.

BRIEF scores were flipped (multiplying by −1.0) for consistency in direction of change across measures used.14 

or Create an Account

Close Modal
Close Modal